Literature DB >> 23037911

Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy.

M S Zinkernagel, S J Hornby, R E MacLaren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23037911      PMCID: PMC3522833          DOI: 10.1038/eye.2012.197

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene.

Authors:  C A Thornton; J P Wymer; Z Simmons; C McClain; R T Moxley
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

2.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

3.  Ciliary and retinal changes in myotonic dystrophy.

Authors:  S Hayasaka; M Kiyosawa; S Katsumata; M Honda; S Takase; K Mizuno
Journal:  Arch Ophthalmol       Date:  1984-01

4.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

5.  Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy.

Authors:  C L Winchester; R K Ferrier; A Sermoni; B J Clark; K J Johnson
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

  5 in total
  1 in total

1.  Polypoidal choroidal vasculopathy in a patient with DMPK-associated myotonic dystrophy.

Authors:  Yuka Iida; Takaaki Hayashi; Teruaki Tokuhisa; Kei Mizobuchi; Shusaku Omoto; Tadashi Nakano
Journal:  Doc Ophthalmol       Date:  2022-03-13       Impact factor: 1.854

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.